Phenotypic pharmacology of novel Complex I inhibitors eliciting tissue repair concurrent to control of inflammation
- PMID: 40782522
- DOI: 10.1016/j.jpet.2025.103661
Phenotypic pharmacology of novel Complex I inhibitors eliciting tissue repair concurrent to control of inflammation
Abstract
A key challenge of regenerative medicine is to provide a signal that can promote and regulate the repair and maintenance of tissues and organ systems to overcome progressive decline. Profiling of novel inhibitors of mitochondrial Complex I (NIC1s) showed differential effects on myeloid and fibroblast cells in vitro and revealed augmented and anatomically appropriate tissue repair in vivo. In a mouse model of collagen-induced arthritis, therapeutic treatment with NIC1s reduced inflammation and bone pathology and concurrently improved the production of anatomically appropriate osteoid, indicative of an osteoblastogenic repair response. In a bleomycin-induced lung fibrosis model, treatment with NIC1s reduced fibrosis and inflammation and mobilized a controlled and appropriate alveolar epithelial repair response that preceded overt antifibrotic and anti-inflammatory effects. We hypothesize that these findings are consistent with a hormetic model of mitochondrial stress transduction, which leads to constrained cell fate selection in myeloid and fibroblast cells. Our work characterizes a new class of Complex I inhibitors and suggests that Complex I may act as a signaling checkpoint to promote and regulate context-dependent repair responses in vivo. SIGNIFICANCE STATEMENT: A key challenge of regenerative medicine is to promote and regulate the repair and maintenance of tissues and organ systems to overcome progressive decline. Augmented and anatomically appropriate tissue repair was demonstrated in disease models of arthritis and lung injury concurrent to ongoing inflammation and/or fibrosis and elicited by a novel mechanistic transduction of mitochondrial stress. These findings provide proof-of-concept for the pharmacological induction of tissue repair using novel inhibitors of mitochondrial Complex I, with important therapeutic implications.
Keywords: Complex I; Fibrosis; Inflammation; Integrated stress response; Regeneration; Tissue Repair.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest Lisa Patel, David Loczenski, Puneeta Nath, and Sam Williams are employees of Istesso Ltd. Fatima Garcia-Raposo, Stephen A. Smith, Paul Vink, and Martyn L. Foster are consultants to Istesso Ltd. Benjamin Moore, James Wood, Lily Morley, and Nicholas Holliday are employees of Excellerate Ltd.
Similar articles
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Platelet-rich therapies for musculoskeletal soft tissue injuries.Cochrane Database Syst Rev. 2013 Dec 23;(12):CD010071. doi: 10.1002/14651858.CD010071.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2014 Apr 29;(4):CD010071. doi: 10.1002/14651858.CD010071.pub3. PMID: 24363098 Updated.
-
Platelet-rich therapies for musculoskeletal soft tissue injuries.Cochrane Database Syst Rev. 2014 Apr 29;2014(4):CD010071. doi: 10.1002/14651858.CD010071.pub3. Cochrane Database Syst Rev. 2014. PMID: 24782334 Free PMC article.
-
Measures implemented in the school setting to contain the COVID-19 pandemic.Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029. Cochrane Database Syst Rev. 2022. Update in: Cochrane Database Syst Rev. 2024 May 2;5:CD015029. doi: 10.1002/14651858.CD015029.pub2. PMID: 35037252 Free PMC article. Updated.
-
Mesh versus non-mesh for inguinal and femoral hernia repair.Cochrane Database Syst Rev. 2018 Sep 13;9(9):CD011517. doi: 10.1002/14651858.CD011517.pub2. Cochrane Database Syst Rev. 2018. PMID: 30209805 Free PMC article.
LinkOut - more resources
Full Text Sources